PhillyPharma Archive: October, 2012

AstraZeneca new CEO gets started but profits fall again

Comment icon 0 Comments
AstraZeneca, which is based in the United Kingdom but has a big operation in Wilmington, said its third-quarter profit dropped more than 50... Read more

Philly-area hospitals got medicine from troubled compounding pharmacy, FDA says

Comment icon 0 Comments
When you have "leaking boiler" and "clean room" in the same sentence in a report about making medicine, it's usually problematic. The Massachusetts... Read more

Health care tech savvy and sexy? Fast Company suggests as much

Comment icon 0 Comments
The November issue of the business magazine Fast Company has a couple of interesting stories and items about new approaches to health care... Read more

CDC says meningitis outbreak up to 285 cases and 23 deaths

Comment icon 0 Comments
The Centers for Disease Control and Prevention said there have been 23 deaths nationally in the fungal meningitis outbreak, which authorities... Read more

N.J. Sierra Club applauds Merck facilities consolidation

Comment icon 0 Comments
We'll end the week by noting, albeit belatedly, that there are moments of peace and harmony between corporations and environmental groups. Yes... Read more

Dr. Andrew Weil tells family docs: Urge bans on soda and pharmaceutical advertising

Comment icon 0 Comments
Philly-born and Harvard-trained, Andrew Weil drew repeated applause Wednesday afternoon when he launched the American Academy of Family Physician's... Read more

Some Medicare drug plans improved star ratings, study says

Comment icon 0 Comments
Twenty eight percent of Medicare Advantage (MA) plans and 49 percent of stand-alone Part D plans (PDPs) improved their star ratings from 2012... Read more

Zaltrap latest example of how pharmaceutical market is unlike most others

Comment icon 0 Comments
Three doctors from Memorial Sloan-Kettering Cancer Center in New York wrote an op-ed piece in Monday's New York Times that illustrated some... Read more